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Recent studies on thymus-derived lymphocyte (T cell)  activation in humans and 
experimental  animals  have  independently  demonstrated  accessory cell  (monocyte) 
dependence for optimal initial mitogenesis (1). Monocyte augmentation of lymphocyte 
proliferation has been documented with cells grown in suspension or soft agar culture, 
and cells stimulated with either mitogen or antigen (2-11). These data, demonstrating 
the  need  for both  a  stimulating  mitogen  and  a  growth-supporting  accessory cell, 
suggest  a  possible requirement  for multiple  independent  signals  for optimal T  cell 
proliferation.  The role of the  monocyte appears to be modulated,  at  least  in  part, 
through  the  production  of lymphocyte-activating factor  (Interleukin  1,  IL-1)  (12). 
Data  derived  from rat  and  mouse systems have indicated  that  macrophage  (M~)- 
derived conditioned media may function to augment both thymocyte and mature T 
cell  mitogenesis  (13-19).  Studies  in  the  murine system have further indicated  that 
semipurified IL-1 may replace the macrophage in respect to the induction  of T  cell 
mitogenesis,  and  that  this  may  occur  through  subsequent  T  cell  production  of 
Interleukin 2 (IL-2) (18,  20). 
In the present work, we have focused our attention on the human system. Purified 
IL-1  has  been  prepared  from  human  cells  and  subsequently  tested  on  human 
thymocytes  and  highly  purified  peripheral  blood  T  cells.  These  studies  further 
reinforce the results in experimental animal systems and demonstrate that obligatory 
M~ signals are needed for the initial commitment to mitogenesis. 
Materials and Methods 
Cell Purification.  T lymphocytes and monocytes were purified from peripheral blood mono- 
nuclear cells (PBL)  as previously  described (7). Briefly, T  cells were derived from the plastic 
nonadherent  mononuclear population  following  E-rosette  formation and  subsequent  nylon 
wool fractionation. Monocytes were derived from the plastic adherent population following a 
total incubation time of 24 h. T cells and monocytes prepared as described  above were >98% 
pure as determined by E rosette,  erythrocyte antibody complement rosette,  surface  immuno- 
globulin,  and nonspecific  esterase  techniques (7). The monocyte contamination of the T  cell 
population was routinely <0.5%. Thymocytes were prepared from fragments of human thymus 
obtained  at  cardiac  surgery  of 4-6-mo-old children.  The  tissue,  aseptically  removed,  was 
immediately placed in Hanks' balanced salt solution  containing 200 U/ml penicillin,  and 200 
/~g/ml streptomycin (Irvine Scientific,  Santa Ana, Calif.).  Each fragment was  finely minced 
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and passed through a sterile 50-mesh stainless steel screen. The minced material was placed in 
cold RPMI-1640 (Irvine Scientific), containing 10% heat-inactivated fetal calf serum (FCS; 
Irvine Scientific), 100 U/ml penicillin, 100 #g/ml streptomycin, 2 mM glutamine, 0.1  mM 
nonessential amino acids (Grand Island Biochemical Co., Grand Island, N. Y.),  1 mM sodium 
pyruvate, and 5 X  10  -5 M fl-mercaptoethanol. Thymocytes were then dispersed by repeated 
pipetting and passage through a  200-mesh  stainless steel  screen.  Erythrocytes were lysed by 
exposure to 0.83% ammonium chloride. The human thymocytes, after final washes  in RPMI- 
1640 medium, were ~95% viable as determined by trypan blue exclusion. 
Preparation of Purified IL-L  IL-1 was prepared according to the procedures of Lachman (21, 
22).  Briefly,  crude conditioned media were initially prepared by culturing PBL in minimal 
essential medium, containing  2 mM glutamine, 10 mM Hepes, 100 U/ml penicillin, 100 #g/ml 
streptomycin, 5% ailogeneic (Grand Island Biochemical Co.) or autologous human serum, and 
10-°M/~-mercaptoethanol. Eschtrichia coli lipopolysaccharide (LPS)  at a concentration of 20 
/.tg/ml  (LPS, 0.55:B8 or 0.27:B8,  Difco Laboratories, Detroit, Mich.) was also included in the 
incubation media. The cells were cultured for 24 h at 37°C, at which time the crude medium 
was clarified by centrifugation. The crude medium was "diafihered" (model DC2, Amicon 
Corp., Scientific Sys. Div., Lexington, Mass.)  with 0.15 M NaC1, 0.05 M Hepes, pH 7.4, using 
a 50,000-mol wt cut-off cartridge. The diafihrate was further purified by uhrafihration through 
a 50,000-mol wt cartridge and this uhrafiltrate was then concentrated using a YM-10 10,000 
mol wt cut-off membrane (Amicon Corp.). The concentrated uhrafihrate was  isoelectrically 
focused  with a 5-50% sucrose  gradient and the fraction found at pH 6.8-7.2 was used as the 
source of semipurified IL-1. Before use in mitogenic assays, the samples were dialyzed against 
0.15 M NaC1 using 3,500-mol  wt cut-off membranes. The sample in the presence of 10% FCS 
was sterile-filtered and stored at -20°C until use. The isoelectrically focused  IL-1  material is 
hereafter referred to as IEF-purified IL-1. 
Further purification of the 6.8-7.2 isoelectric  point IL-1  activity was accomplished by gel 
electrophoresis (21). The material found in the 6.8-7.2 fractions was collected and dialyzed 
against Tris-glyeine, pH 8.9.  7% acrylamide disc gels, under nondenaturing conditions, were 
next used for isolation of that material which electrophoresed with an Rf value of 0.36. The IL- 
l  was  recovered from the appropriately located gel  slice by electrophoretic extraction with 
subsequent dialysis against 0.15  M  NaCl using 3,500-mol  wt  cut-off membranes. After the 
addition of 10% FCS and sterile filtration, the IL-1 was stored at -20°C until use. This material 
is hereafter referred to as preparative gel-purified IL-1. 
Preparation of Mt~-conditioned Media.  For the preparation of crude conditioned media from 
highly purified Mq~, cells were grown in RPMI-1640 medium supplemented with 2% FCS or 
2%  human AB serum. Monocytes were used at concentrations of 0.5-1.0 ×  106/ml  media. 
Monocytes were  cultured at  37°C  for  24  h.  The  samples were  subsequently clarified  by 
centrifugation, dialyzed overnight against RPMI-1640 medium, and stored at 4°C until use. 
Mitogenic Assays.  T  cells were routinely cultured in tubes (Falcon 3033, Falcon Labware, 
Div. of Becton Dickinson and Co., Oxnard, Calif.) with RPMI-1640 medium. The medium 
was supplemented with FCS (10% vol/vol), penicillin,  streptomycin, L-glutamine, and 5 ×  10  -5 
M fl-mercaptoethanol. Thymocyte medium was further su6pplemented with 0.1 mM nonessen- 
tial  amino acids  and  1 mM  sodium  pyruvate.  1  ×  10  T  cells/ml were  stimulated with 
phytohemagglutinin-M  at a concentration of 0.75-1.0%.  Thymocytes, at 5 ×  106 cells/ml were 
stimulated with eoneanavalin A at 5/~g/ml (23). At the times indicated in the text, the cells 
were labeled as shown in table legends. The cells were subsequently harvested and the acid- 
insoluble material was collected on Whatman GF/C filters (Whatman, Inc., Clifton, N. J.) and 
counted in Scintiverse cocktail (Fisher Scientific Co., Pittsburgh, Pa.) using a Beckman LS8 i00 
liquid scintillation spectrometer (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). 
All experimental determinations were performed in duplicate or triplicate. Standard errors of 
the mean for thymocytes in the presence of IL-1 and lectin were routinely 15%. Standard errors 
of T cells in the presence of IL- 1 and lectin were  19%. 
Immunologic Marker Determinations.  These assays were performed as previously described (7). 
Results 
IEF-purified IL-1  had a  protein concentration of <1  ng:25/~1. This material was 
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IL-1  was  mitogenic for  mouse thymocytes at  a  dilution of at  least  1:32.  Neither of 
these materials could be shown to support the long-term growth of cytotoxic T  cells 
and were therefore both considered free of IL-2 activity. 
The  IEF-purified  IL-1  was  tested  for lectin-augmenting  activity  on  human  thy- 
mocytes and purified T  cells.  Data  from representative  experiments  can  be  seen  in 
Table  I.  The  IL-1  demonstrated  human thymocyte lectin-augmenting  activity  that 
diminished  upon serial dilution, although some activity was still  apparent  at  1:240. 
Highly purified human T  cells also responded to IL-1, in the presence of lectin, with 
dilutional characteristics similar to those seen with the thymocytes. The mean T  cell 
mitogen  response in  the  presence of IEF-purified  samples  of IL-1  compared  to  the 
TABLE  I 
Effect of IEF-purified IL-1 on Human  Thymocytes and T  Cells 
[3H]Tdr incorporation* 
-  Con A  +  Con A 
Thymocytes~  2,150  14,941 
Thymocytes +  IL-I 
1/30  3,027  53,20l 
1/60  3,854  51,075 
l/t20  3,105  35,769 
1/240  3,209  26,671 
-  PHA  +  PHA 
T  cells§  105  5,428 
T  cells +  M~  421  24,676 
T  cells +  IL-I 
1/15  421  21,152 
1/30  227  28,458 
1/60  157  9,437 
1/120  285  1,847 
*  18  20  h  before harvest  the cells were labeled  with  1 /.tCi/ml  [3H]Tdr  (6.7  Ci/mMol). 
The  results  represent  the  mean  of  multiple  determinations  from  a  representative 
experiment. 
:~ Thymocytes were cultured  for a  total of 72 h  at a  concentration  of 5  ×  10  n cells/ml. 
§ T  cells were cultured  for 96  h  at  a  concentration  of 1.0  ×  10~/ml.  Monocytes,  where 
added,  were  used  at  0.2  ×  108/ml.  The  IL-I  material  was diluted  with  RPMI-1640 
medium and added at the initiation of culture  for both  the thymocytes and the T  cells. 
TABLE II 
Effect of Macrophage-conditioned  Media on Human  T Cell Proliferation 
I3H]Tdr incorporation* 
-  PHA  +  PHA 
T  cells  263  8,351 
T  cells +  Mth  683  39,851 
T  cells +  conditioned  media~: 
(Mq~) 0.5 ×  10n/ml  469  15,135 
(M4,)  1.0 x  106/ml§  1374  28,652 
*  18-20  h  before harvest  the cells were labeled  with  1 #Ci/nd  [:~H]Tdr (6.7  Ci/mMol). 
The  results  represent  the  mean of multiple  independent  experimental  determinations 
(n =  3-7). 
:1: The  conditioned  media  were  prepared  by  culturing  purified  M~b at  0.5  or  1.0  ×  10  ~ 
cells/ml.  The cells were incubated  24 h  at  37°C. The conditioned  media were utilized 
as 20% of the  final  volume in  the  mitogenic assay as preliminary  data  indicated  this 
concentration  to yield optimum mitogenesis. 
§ The  Mdg-derived conditioned  media  were  initially  tested  on  murme  thymocytes  (23). 
The  mean  A  cmmts  per  minule  of thymocytes  exposed  to  lectin  in  lhe  presence  of 
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TABLE  III 
Effect of Gel-purified IL-1 on Human  Thymocytes and T Cells 
[3H]Tdr incorporation* 
-  Con A  +  Con A 
Thymocytes  2,150  14,941 
Thymocytes +  IL-I 
1/20  2,830  45,220 
1/40  3,669  44,354 
1/80  3,453  51,785 
-- PHA  +  PHA 
T  cells  292  7,968 
T cells +  M~  274  30,398 
T cells +  IL-I 
1/10  NT:t:  16,111 
1/20  16,365 
1/40  19,295 
1/80  28,164 
* The thymocytes were cultured for 72 h.  18 h before harvest, the ceils were labeled with 
1 ,ttCi/ml  [3H]Tdr (6.7 Ci/mMol). The T  cells were grown for 96 h. 3 h before harvest, 
the cells were labeled with 2 p.Ci/ml [aH]Tdr (20 Ci/mMol). The results  represent the 
mean  of  duplicate  or  triplicate  determinations  at  each  point  from  representative 
experiments. 
:~ NT, not tested. 
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proliferation with an intact M~ was  57.0 ±  19%  (n =  5).  The T  cell response with 
IEF-purified IL-1  (<1  ng protein:25/xl added sample) compared favorably with the 
responsiveness seen using crude IL-1  containing conditioned media  prepared  from 
highly purified macrophages (Table II). For these experiments, monocyte cell number 
was  varied during conditioned media preparation so that addition of this media as 
20% (vol/vol) of the final mitogenic assay would mimic the effect of optimal T  cell to 
monocyte ratio of 10:1  to 5:1. 
Experiments using preparative gel-purified IL-1 can be seen in Table III.  Again, 
both the human thymocytes and the human T  cells responded to the presence of IL- 
l with augmentation of lectin-stimulated mitogenesis. Furthermore, these experiments 
underscore the sensitivity of the lymphocytes to small concentrations of monokines as 
was seen above with IEF-purified samples. 
Discussion 
These results demonstrate the ability oflL-1 purified from human PBL to effectively 
augment  lectin-stimulated  mitogenesis  with  both  the  human  thymocyte and  the 
human  T  cell.  This  represents  the  first  demonstration  of such  activity where  all 
elements were produced and tested in the human system. 
Results with experimental animal systems have demonstrated that the monocyte or 
monocyte-derived soluble products are necessary for T  cell-dependent production of 
IL-2  (18,  20,  24).  These  studies  have  recently  included  a  demonstration  of IL-I 
mitogenic augmentation of murine splenic T  cells and lymph node cells (18,  19). The 
implication of these studies is that IL-1 modulates T  cell proliferation by regulating 
the production oflL-2 (18). IL-2 has therefore been proposed as the ultimate mitogen 
regulating cell division (25).  Studies are currently underway attempting to correlate 
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division  to  determine  whether  this  lymphokine  and  lymphocyte  proliferation  are 
invariably linked. 
The apparent ability of relatively small amounts of highly purified preparations of 
IL-1 to augment lectin responsiveness is significant in respect to the role of physical 
contact  in  the  genesis  of lymphocyte  proliferation.  Previous  experimentation  has 
indicated that lymphocyte-macrophage cell to cell interaction represents a component 
of lectin- and antigen-stimulated proliferation (7, 26, 27).  Studies have indicated that 
lymphocyte blastogenesis is frequently observed with the T  cell bound either directly 
to the macrophage or to another lymphocyte which is itself bound to the macrophage. 
This close approximation of the two cell types would ensure relatively high concen- 
tration  gradients  of  both  monokines  and  lymphokines,  which  may  subsequently 
control  proliferation.  The  contact  between  the  cells  could  also  amplify  feedback 
control  mechanisms for the  termination  of either  IL-1  or  IL-2 production  and/or 
release. The present  data  indicate  that  IL-1  purified  to a  high degree of specificity 
may function in concentrations that could possibly be achieved within a physiological 
environment of lymphocyte-macrophage contact. 
Summary 
Human Interleukin  1 (IL-1) purified by molecular weight fractionation, isoelectric 
focusing, and gel electrophoresis has been tested on human thymocytes and highly 
purified  human  T  cells.  IL-1  prepared in  this manner could not  support  the long- 
term growth of T  cells yet would  augment  lectin-stimulated  mitogenesis.  The IL-1 
preparations were shown to possess this lectin-augmenting activity at dilutions con- 
taining < 1 ng of measurable protein.  These data  are in agreement with the model 
that IL-1 stimulates production of IL-2 from lectin-stimulated lymphocytes. 
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